Biotech investing saw growth in 2024, with RA Capital leading VCs. FDA cancels flu vaccine meeting, Pfizer hires ex-FDA ...

CHMP recommends approval of Regeneron's Lynozyfic, Krystal's Vyjuvek, Accord's trabectedin, Takeda's Deqsiga, and 16 label ...

Industry groups are looking to push government drug price negotiation and PBM reforms into a massive Republican domestic ...

Infectious disease professionals, bracing for an overhaul of the CDC's vaccine advisory group, are in discussions to stand up ...